From the Archives: Treating Opioid Addiction

It is estimated that between 26.4 million and 36 million people abuse opioids worldwide; the US government estimates that 2.1 million people in the United States have substance use disorders related to prescription opioid pain relievers in 2012 and another 467,000 are addicted to heroin. Consequences include a spike in the number of unintentional overdose deaths from prescription pain relievers (including the recent death of the musician Prince), and growing evidence to suggest a relationship between increased non-medical use of opioid analgesics and heroin abuse in the US.

OBrien_Charles_featWhat can we do to help? This spring, Charles O’Brien and colleagues reported results of the latest in a series of studies testing the drug naltrexone as a preventive against opioid relapse in people greatly at risk for relapse: formerly addicted convicts. “This U.S. multisite, open-label, randomized effectiveness trial showed that among adult offenders who had a history of opioid dependence, the rate of relapse was lower among participants assigned to extended-release naltrexone than among those assigned to usual treatment,” they write.

Continue reading

June 7: Free Public Briefing on Opioid Dependence

Addiction

Image: Shutterstock

Opioid Dependence

A Public Luncheon Briefing
Hosted by the American Association for the Advancement of Science (AAAS)
Through the Support of the Dana Foundation
In Conjunction with the Congressional Neuroscience Caucus

Tuesday, June 7 2016
12-1 p.m.
B339 Rayburn House Office Building
Lunch Provided
*RSVP: https://www.cvent.com/c/express/6e694162-d32c-421d-b68f-071d95f5f712

The abuse of and addiction to opioids is a serious public health problem; more people died from drug overdoses in 2014 than any other year on record, according to the CDC, and the majority of these deaths involved an opioid. U.S. lawmakers have taken note with a series of actions this year aimed at addressing this. Come and hear from experts about the science behind the epidemic.

Continue reading

The Science and Policy of Marijuana

Science and policy are often in tension with one another, but in the case of cannabis, as medicinal or recreational marijuana, science seems to be playing catch-up.

“Cannabis was scheduled [made illegal] in the absence of science,” and now is being legalized in some areas, still in the near-absence of science, said J. Michael Bostwick, a practicing psychiatrist and a senior associate dean at Mayo Medical School. In 1970, when Congress classified cannabis as Schedule 1 (“drugs with no currently accepted medical use and a high potential for abuse”), scientists did not know which neuronal receptors it activated or what exactly in the substance was causing which effects.

aaas nida

NIDA’s Nora Volkow and DC council member David Grosso listen to psychiatrist J. Michael Bostwick answer a question from the audience at AAAS.

More than four decades later (and 5,000 years since people first started using it as pain reliever), we still don’t know much more of the botanical substance’s potential as a medicine, because its Schedule 1 status means US researchers have to jump through hoops at several different agencies to get access to the legal federal supply. That’s just the start, science-wise: As with any plant, cannabis varies widely in quality, strength, and in what other compounds are bound within the plant, so research—and comparing previous studies in the US and elsewhere—can be tricky.

Continue reading

March 30: The Science and Policy of Marijuana

AAAS logoThe American Association for the Advancement of Science and the Dana Foundation are pleased to invite you to the first event of the 2016 series on Neuroscience & Society:

The Science and Policy of Marijuana

5:30 p.m.
March 30, 2016
Reception to Follow

AAAS Headquarters
1200 New York Ave NW
Washington, DC
Continue reading

National Drug & Alcohol Facts Week (January 25-31)

ndfw_300_250_0_0

On Monday, National Drug & Alcohol Facts Week began, sparking local events across the country in an effort to “shatter the myths” about drugs and alcohol, particularly among teens.

Continue reading

%d bloggers like this: